Cannabis stock report: Pot stocks flat as market analyst say Aphria is still a “Buy”

Investors looking for some good news were buoyed by the fact that Haywood Capital Markets analyst Neal Gilmer kept Licensed Producer Aphria at a “Buy” rating.
Read
Aug 11 CBD

These are the best brands of CBD to help you celebrate post-National CBD Day

Here’s a list of some of the best — and most interesting — CBD products to help keep the celebration going!
Read

Cannabis stock report: Pot stocks down as GW Pharma finds more success with Epidiolex

In perhaps the biggest news of last week, GW Pharmaceuticals and Greenwich Biosciences Inc. put out a joint statement announcing the Food and Drug Administration’s expanded approval for their CBD-based drug Epidiolex.
Read
Aug 10 Features

American Heart Association warns against cannabis use, calls for more research

According to a new report released by the American Heart Association, cannabis use “shows substantial risks, no benefits for cardiovascular health.”
Read
Innovative Industrial Properties Inc.
106.6350
7.03
7.05%
Zynerba Pharmaceuticals Inc.
10.5900
-0.37
-3.38%
Scotts Miracle-Gro Company (The)
111.9000
2.37
2.16%
Corbus Pharmaceuticals Holdings Inc.
6.1000
0.10
1.67%
Cara Therapeutics Inc.
23.4000
0.37
1.61%
Marijuana Stocks
More News